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2The syntheses of phenacyl N-(2,2-dimethyl-2H-azirin-3-yl)-L-prolinate and allyl
N-(2,2-dimethyl-2H-azirin-3-yl)-L-prolinate are reported. Reactions of these 2H-
azirin-3-amines with Z-protected amino acids have shown them to be suitable
synthons for the Aib-Pro unit in peptide synthesis. After incorporation into the
peptide by means of the ‘azirine/oxazolone method’, the C-termini of the resulting
peptides were deprotected selectively with Zn in AcOH or with a mild Pd0-
promoted procedure, respectively.
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31. Introduction. – Peptides that contain α,α-disubstituted α-amino acids are of
interest because the rigidity of their peptide backbones leads to a stabilization or
even a promotion of secondary structures, such as β-turns or helices [1–4].
Moreover, a group of peptide antibiotics, the peptaibols, contain a high proportion
of α ,α-disubstituted α-amino acids, in particular α-aminoisobutyric acid (Aib)
[5]. A valuable and convenient method for the introduction of these sterically
demanding α,α-disubstituted α-amino acids is the ‘azirine/oxazolone method’
[6–8]. Thus, the reaction of 2H-azirin-3-amines 1, which represent the amino acid
synthons, with amino or peptide acids leads to peptide amides, the terminal amide
bonds of which can be hydrolyzed selectively to give the extended peptide acids.
This method has been applied successfully in the introduction of a variety of α,α-
disubstituted α-amino acids into peptides, and it has found application in the
synthesis of some peptaibols or segments thereof [9–18].
Recently, we adapted the ‘azirine/oxazolone method’ to solid-phase conditions,
in order to additionally profit from their benefits [19]. Moreover, it was shown
that also on solid phase the method is not limited to the Aib synthon 1a, and it
was extended successfully to the 1-aminocyclopentane-1-carboxylic acid synthon
(1b), the 4-amino-3,4,5,6-tetrahydro-2H-pyran-4-carboxylic acid synthon (1c),
and the α-methylphenylalanine synthon (1d) [20].
Since the Aib-Pro motif is widespread in peptaibols – in fact, 266 out of the
309 so far known peptaibol sequences contain the Aib-Pro unit [21] – it was of
great interest to introduce this unit directly. In solution-phase chemistry, the
introduction of the Aib-Pro unit was accomplished with the use of dipeptide
synthon 2 [22]. Unexpectedly, its use on solid phase was not successful due to the
4incompatibility of the linker and the strong basic media which is required for the
saponification of the methyl ester [23]. In the course of working out a new
strategy for the introduction of the Aib-Pro motif on solid phase, a 2H-azirin-3-
amine with an easily removable carboxy-protecting group was required.
Formula Collection
Herein, we present the synthesis, chemical characterization, and briefly, the use
in solution-phase peptide synthesis of the novel Aib-Pro synthons 3a and 3b.
After introduction into the peptide, the carboxy termini of the resulting extended
peptides can be deprotected with Zn in AcOH or with a mild Pd0-promoted
procedure, respectively.
2. Results and Discussion. –  Since the synthesis of 2H-azirin-3-amines 1 is
performed under acidic conditions, the range of carboxy-protecting groups is
limited to those which are base labile, which can be removed by reduction, or
which are labile towards transition metal complexes, but feature a good stability
towards acids. The fluorenylmethyl (Fm) [24][25] and 2-(4-
nitrophenylsulfonyl)ethyl [26] protecting groups, which can be cleaved by
treatment with secondary amines, should fulfill these prerequisites. Hence, we
aimed at the synthesis of the 2H-azirin-3-amines 4a and 4b as outlined in Scheme
1 . After saponification of methyl prolinate 5  with LiOH and subsequent
carbodiimide induced coupling of acid 6 with the corresponding alcohols, the
5obtained amides 7a and 7b  were converted to the thioamides 8a  and 8b ,
respectively, by thionation with Lawesson reagent. A slightly modified2)
procedure compared to that of Wipf [27] did not lead to the desired 2H-azirin-3-
amines 4 a  and 4 b . Consequently, we headed for 4 b  v ia  the 2-(4-
nitrophenylsulfanyl)ethyl protected 2H-azirin-3-amine 4c. This route comprises
the ‘safety catch principle’ since the activation for the β-elimination is realized
after the azirine synthesis by an oxidation of the sulfanyl group3). However, the
synthesis of 4c failed too.
Scheme 1
The phenacyl and allyl ester protecting groups, which can be removed by
treatment with Zn/AcOH [28] and Pd(Ph3P)4/PhSiH3 [29], respectively, were the
next promising candidates for proline protection. The synthesis of the phenacyl
and allyl ester protected dipeptide synthons 3a and 3b started with the preparation
of the esters 9a and 9b by alkylation of 6 with phenacyl bromide and allyl
bromide, respectively (Scheme 2). A direct access from L-proline was
accomplished for 9b. For this purpose, L-proline was esterified with allyl alcohol
and then acylated with isobutyryl chloride. After thionation of the amides 9a and
9b with Lawesson reagent, the synthesis of 3a  and 3b  was achieved by
consecutive treatment of the obtained thioamides 10a and 10b and catalytic
                                                 
2) In order to prevent early β-elimination, EtN(iPr)2 was used instead of DABCO.
3) A preliminary test showed that 2 is stable under mild oxidative conditions
(TPAP, NMO).
6amounts of DMF in CH2Cl2 with COCl2, evaporation of the solvent, addition of
THF and 1,4-diazabicyclo[2.2.2]octane (DABCO), filtration, and treatment with
NaN3 (cf. [27]). After chromatographic workup, the 2H-azirin-3-amines 3a and 3b
were obtained in 58 and 62% yield, respectively, as pale yellow oils.
Scheme 2
For a chemical characterization and for the examination of the reactivity of the
novel 2H-azirin-3-amines 3a and 3b, they were treated with thiobenzoic acid
(Scheme 3). The reactions proceeded smoothly and the thiopeptides 11 were
obtained in high yield (93 and 94%, resp.). In the case of 11a, crystals suitable for
an X-ray crystal-structure determination were obtained (Figure). Compound 11a
in the crystal is enantiomerically pure and the absolute configuration of the
molecule has been determined independently by the diffraction experiment. The
molecule has the expected S-configuration. The amide group forms an
intermolecular H-bond with the S-atom of an adjacent molecule and thereby links
the molecules into extended chains, which run parallel to the [0 1 0] direction and
can be described by the graph set motif [30] of C(5).
Scheme 3
Figure
In order to examine the use of 3a and 3b in peptide synthesis, reactions with N-
protected amino acids were performed. The Aib-Pro synthon 3a was reacted with
7Z-Ile-OH and Z-Phe-OH to give the tripeptides 12a and 13, respectively, while
the reaction of 3b with Z-Ile-OH yielded the tripeptide 12b (Scheme 4). All
reactions gave the products in high purity and in very good yields (90–94%, after
chromatographic workup). Then, the selective deprotection of the C-terminus of
13 was accomplished with Zn-powder in AcOH, and yielded peptide acid 14.
Deprotection of the phenacyl esters with Bu4N+F¯ in DMF [32] would possibly be
transferable to solid-phase conditions, which is the ultimate use of the new
azirine. Therefore, 12a and 13 were subjected to Bu4N+F¯ (3 equiv.) in DMF and
THF, respectively, but in none of the experiments a peptide acid 14 or 15,
respectively, could be isolated.
The deprotection of the C-terminus can be performed under milder conditions
if synthon 3b is used in the peptide chain extension. This was illustrated with the
model peptide 12b, in which the allyl ester group was smoothly removed by
treatment with Pd(Ph3P)4 and PhSiH3 in CH2Cl2 to give peptide acid 15.
Moreover, these deprotecting conditions should be applicable on solid phase.
Scheme 4
3. Conclusion. – The novel 2H-azirin-3-amines 3a and 3b, which contain a
phenacyl ester and an allyl ester, respectively, as carboxy-protecting group, have
been synthesized. These azirines represent Aib-Pro synthons, and this dipeptide
unit can be introduced conveniently into peptides by the ‘azirine/oxazolone
method’. The C-terminus of the resulting peptide esters can be deprotected under
non-basic conditions, i.e. by treatment with Zn/AcOH and Pd(Ph3P)4/PhSiH3. The
8use of 3a and 3b as building blocks for the ‘azirine/oxazolone method’ on solid
phase are in progress.
Experimental Part
1. General. – Reagents were obtained from commercial suppliers and were
used without further purification. Solvents were purified by standard procedures.
Compound 5 was prepared according to [22]. TLC: Merck TLC aluminum sheets,
silica gel 60 F254. Prep. TLC: Merck PLC plates (glass), silica gel 60 F254. Column
chromatography (CC): Uetikon-Chemie, silica gel C-560. M.p.: Büchi Melting
Point B-450 apparatus, uncorrected. IR Spectra: Perkin-Elmer, Spectrum One FT-
IR spectrophotometer; unless otherwise stated in KBr, absorptions in cm–1. NMR
Spectra: Bruker ARX-300, Bruker AV-600, or Bruker AV-700 instruments; in
CDCl3, δ in ppm, TMS as internal standard, coupling constants J in Hz. 2D-NMR
experiments were performed for assignment of the signals. In 1H- and 13C-NMR
spectra where two conformers were observed, only the signals of the major
conformer are shown. The ratio of the two conformers is given in parentheses. MS
(m /z  (rel.%)): Bruker ESQUIRE-LC quadrupole ion trap instrument.
A b b r e v i a t i o n s :  Aib: α -aminoisobutyric acid;  DABCO: 1,4-
diazabicyclo[2.2.2]octane; DCC: N,N’-dicyclohexylcarbodiimid; DMAP: 4-(N,N-
d i m e t h y l a m i n o ) p y r i d i n e ;  E D C I :  N - e t h y l -N’-[3-
(dimethylamino)propyl]carbodiimide hydrochloride; PPY: 4-pyrrolidinopyridine.
2. Synthesis of 2H-Azirin-3-amines 3a and 3 b. N-(2-Methylpropanoyl)-L-
proline (6). A soln. of methyl N-(2-methylpropanoyl)-L-prolinate (5) (2.000 g,
910.04 mmol) and LiOH . H2O (0.843 g, 20.11 mmol) in THF/MeOH/H2O (3:1:1;
100 ml) was stirred at r.t. overnight. The org. solvents were removed under
reduced pressure and the residue was washed with Et2O. At 0°, the aq. phase was
acidified with 1M HCl and saturated with NaCl. After extraction with CH2Cl2, the
combined org. layers were washed with brine, dried (MgSO4), and concentrated
i.v. to give 6 (1.775 g, 96%). Colorless powder. M.p. 122.6–123.7°. IR: 2969s,
2942s, 2879s, 2771m, 2606m, 1721vs, 1600vs, 1509w, 1478s, 1446vs, 1332m,
1266m, 1254s, 1228vs, 1191s, 1167m, 1154m, 1092s, 1042w, 968w, 914m, 838w,
808w, 752w. 1H-NMR (300 MHz, conformers (95:5)): 10.9–9.6 (br. s, CO2H);
4.61–4.57 (m, CH(α)(Pro)); 3.66–3.61, 3.58–3.50 (2m, CH2(δ)(Pro)); 2.72 (sept.,
J = 6.8, Me2CH); 2.44–2.40, 2.10–1.99 (2m, CH2(β)(Pro), CH2(γ)(Pro)); 1.53,
1.16 (2d, J = 6.8, 2 Me). 13C-NMR (75 MHz): 179.1, 172.8 (2s, 2 CO); 60.0 (d,
CH(α)(Pro)); 47.6 (t, CH2(δ)(Pro)); 32.5 (d, Me2CH); 27.4, 24.9 (2t, CH2(β)(Pro),
CH2(γ)(Pro)); 19.0, 18.5 (2q, 2 Me). ESI-MS (MeOH): 208 (100, [M+Na]+). Anal.
calc. for C9H15NO3 (185.22): C 58.36, H 8.16, N 7.56; found: C 58.51, H 8.06, N
7.77.
Phenacyl N-(2-Methylpropanoyl)-L-prolinate (9a). A mixture of 6 (0.801 g,
4.32 mmol), Et3N (601 µl, 4.32 mmol) and phenacyl bromide (0.860g, 4.32
mmol) in AcOEt (20 ml) was stirred at r.t. overnight. The mixture was filtered,
and the soln. was concentrated i.v. CC (SiO2, AcOEt/hexane 6:4) yielded 9a
(1.280 g, 98%). Colorless oil. IR (film): 3488m, 3391w, 3270w, 3063s, 2974vs,
2935vs, 2876vs, 1755vs, 1701vs, 1644vs, 1598vs, 1582vs, 1470vs, 1449vs,
1426vs, 1376vs, 1364vs, 1318vs, 1279vs, 1230vs, 1173vs, 1092vs, 1043s,
1001vs, 973vs, 953vs, 921m, 886m, 851m, 810s, 753vs, 735vs . 1H-NMR (300
10
MHz, conformers (85:15)): 7.90–7.87, 7.63–7.57, 7.52–7.45 (3m, 5 arom. H);
5.55, 5.21 (AB , J  = 16.5, CH2CO); 4.68–4.62 (m, CH(α)(Pro)); 3.76–3.67,
3.62–3.54 (2m, CH2(δ)(Pro)); 2.69 (sept., J = 6.8, Me2CH); 2.42–2.13, 2.10–1.97
(2m, CH2(β)(Pro), CH2(γ)(Pro)); 1.15, 1.14 (2d, J = 6.8, 2 Me). 13C-NMR (75
MHz): 192.2 (s, CO(carbonyl)); 175.9 (s, CO(amide)); 171.8 (s, CO(ester)); 134.1
(s, arom. C); 133.8, 128.8, 127.6 (3d, 5 arom. CH); 60.0 (t, CH2CO); 58.5 (d,
CH(α)(Pro)); 46.7 (t, CH2(δ)(Pro)); 32.2 (d, Me2CH); 29.1, 24.8 (2t, CH2(β)(Pro),
CH2(γ)(Pro)); 18.7, 18.6 (2q, 2 Me). ESI-MS (MeOH, NaI): 326 (100, [M+Na]+).
Anal. calc. for C17H21NO4 (303.35): C 67.31, H 6.98, N 4.62; found: C 67.11, H
6.61, N 4.62.
Allyl N-(2-Methylpropanoyl)-L-prolinate (9b). From 6. A soln. of allyl
bromide (22.8 ml, 269.50 mmol) and aliquat 336 (21.6 g) in CH2Cl2 (75 ml) was
added to a soln. of 6 (10.004 g, 54.01 mmol) and NaHCO3 (4.539 g, 54.03 mmol)
in H2O (75 ml) at 0°. The mixture was vigorously stirred at r.t. for 3 d, then H2O
(50 ml) was added and the suspension was extracted with CH2Cl2. The combined
org. layers were dried (MgSO4) and concentrated i.v. CC (SiO2, AcOEt/hexane
4:6 → 1:1) yielded 9b (11.328 g, 93%). Colorless liquid.
From L-Proline. At –20°, SOCl2 (1.70 ml, 23.36 mmol) was added to allyl
alcohol (12 ml, 176.45 mmol), then L-proline (2.000 g, 17.37 mmol) was added,
and the mixture was slowly heated to 65° and stirred at 65° for 1 h. The mixture
was concentrated i.v., the residue was dissolved in AcOEt (60 ml), and Et3N (5.05
ml, 36.23 mmol) and isobutyryl chloride (1.85 ml, 17.52 mmol) were added at 0°.
The mixture was stirred at r.t. overnight, H2O (20 ml) was added, and the mixture
was extracted with AcOEt. The combined org. layers were dried (MgSO4) and
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concentrated i.v. CC (AcOEt/hexane 1:1) yielded 9b (3.164 g, 81%). Colorless
liquid. IR (film): 3568w, 3479w, 3085w, 2973vs, 2935s, 2877s, 1745vs, 1650vs,
1741vs, 1426vs, 1377s, 1362s, 1318vs, 1274s, 1242s, 1177vs, 1091s, 1044m,
990s, 954m, 930s, 882w, 819w, 754m. 1H-NMR (300 MHz, conformers (85:15)):
5.97–5.84 (m , CH2=CH); 5.37–5.20 (m , CH 2=CH); 4.68–4.60 (m , CH2O);
4.53–4.48 (m, CH(α)(Pro)); 3.73–3.64, 3.62–3.53 (2m, CH2(δ)(Pro)); 2.68 (sept.,
J = 6.8, Me2CH); 2.29–1.90 (m, CH2(β)(Pro), CH2(γ)(Pro)); 1.16, 1.13 (2d, J =
6.8, 2 Me). 13C-NMR (75 MHz): 176.0 (s, CO(amide)); 172.3 (s, CO(ester));
132.2 (d, CH2=CH); 118.4 (t, CH2=CH); 65.7 (t, CH2O); 58.9 (d, CH(α)(Pro));
46.9 (t, CH2(δ)(Pro)); 32.4 (d, Me2CH); 29.3, 25.1 (2t, CH2(β)(Pro), CH2(γ)(Pro));
19.0, 18.8 (2q, 2 Me). ESI-MS (MeOH): 298 (13, [M+Na+MeOH+H2O]+), 248
(100, [M+Na]+). Anal. calc. for C12H19NO3 (225.28): C 63.98, H 8.50, N 6.22;
found: C 63.71, H 8.45, N 6.13.
Phenacyl N-(2-Methylpropanthioyl)-L-prolinate (10a). A suspension of
Lawesson reagent (dried i.v., 444 mg, 1.10 mmol) and 9a (600 mg, 1.98 mmol) in
toluene (20 ml) was heated at 90° (oilbath) for 1 h. After cooling to r.t., the
mixture was filtered, and the solvent was evaporated. CC (SiO2, CH2Cl2/MeOH
200:1 → 100:1) yielded 10a (571 mg, 90%). Colorless solid. M.p. 83.9–84.9°. IR:
2976m, 2946w, 2928w, 2868w, 1749vs, 1701vs, 1596m, 1579w, 1468s, 1445vs,
1419m, 1373m, 1356m, 1345m, 1309w, 1263m, 1255m, 1237v, 1192vs, 1173s,
1156s, 1130m, 1013s, 1000w, 967m, 910w, 815w, 757m, 735w, 690s. 1H-NMR
(600 MHz, conformers (87:13)): 7.90–7.88, 7.65–7.59, 7.52–7.47 (3m, 5 arom.
H); 5.54, 5.25 (AB, J = 16.4, CH2CO); 5.27–5.25 (m, CH(α)(Pro)); 3.97–3.93,
3.79–3.75 (2m, CH2(δ)(Pro)); 3.07 (sept., J = 6.6, Me2CH); 2.56–2.50, 2.40–2.31,
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2.21–2.14 (3m, CH2(β)(Pro), CH2(γ)(Pro)); 1.26, 1.23 (2d, J = 6.6, 2 Me). 13C-
NMR (150 MHz): 209.9 (s, CS); 192.2 (s, CO(carbonyl)); 170.0 (s, CO(ester));
134.1 (s, 1 arom. C); 134.0, 128.9, 127.7 (3d, 5 arom. CH); 66.3 (t, CH2CO); 65.2
(d, CH(α)(Pro)); 50.4 (t, CH2(δ)(Pro)); 38.7 (d , Me2CH); 29.0, 24.7 (2t,
CH2(β)(Pro), CH2(γ)(Pro)); 22.7, 22.4 (2q, 2 Me). ESI-MS (MeOH, NaI): 342
(100, [M+Na]+). Anal. calc. for C17H21NO3S  (319.42): C 63.92, H 6.63, N 4.39, S
10.04; found: C 64.07, H 6.37, N 4.30, S 10.08.
Allyl N-(2-Methylpropanthioyl)-L-prolinate (10b). A suspension of Lawesson
reagent (dried i.v., 5.584 g, 13.81 mmol) and 9b (5.618 g, 24.94 mmol) in toluene
(70 ml) was heated at 95° (oilbath) for 1 h. After cooling to r.t., the mixture was
filtered, and the solvent was evaporated. CC (SiO2, CH2Cl2/MeOH 400:1 →
100:1) yielded 10b (5.439 g, 90%). Pale yellow oil. IR (film): 3084w, 2973vs,
2931s, 2878s, 1742vs, 1648w, 1440vs, 1381s, 1360s, 1333vs, 1268vs, 1227vs,
1191vs, 1170vs, 1126s, 1088m, 1046m, 1016vs, 989s, 969s, 930s, 874m, 784w.
1H-NMR (700 MHz, conformers (83:17)): 5.94–5.88 (m, CH2=CH); 5.37–5.23 (m,
CH2=CH); 5.13–5.11 (m , CH(α)(Pro)); 4.67–4.60 (m , CH2O); 3.93–3.88,
3.78–3.74 (2m, CH2(δ)(Pro)); 3.05 (sept., J = 6.6, Me2CH); 2.30–2.25, 2.23–2.17,
2.14–2.09  (3m, CH2(β)(Pro), CH2(γ)(Pro)); 1.25, 1.24 (2d, J = 6.6, 2 Me). 13C-
NMR (175 MHz): 209.9 (s, CS); 170.5 (s, CO); 132.1 (d, CH2=CH); 118.7 (t,
CH2=CH); 66.0 (t, CH2O); 65.4 (d, CH(α)(Pro)); 50.4 (t, CH2(δ)(Pro)); 38.9 (d,
Me2CH); 29.0, 24.9 (2t, CH2(β)(Pro), CH2(γ)(Pro)); 22.9, 22.5 (2q, 2 Me). ESI-
MS (MeOH): 264 (100, [M+Na]+). Anal. calc. for C12H19NO2S (241.35): C 59.72,
H 7.93, N 5.80, S 13.29; found: C 59.80, H 7.65, N 5.58, S 13.07.
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Phenacyl N-(2,2-Dimethyl-2H-azirin-3-yl)-L-prolinate (3a). A soln. of COCl2
in toluene (20%, 1.8 ml, 3.47 mmol) was added to a soln. of 10a (1.001 g, 3.13
mmol) and 3 drops of DMF in CH2Cl2 (10 ml) at 0°, the mixture was stirred for 30
min at 0°, and the volatiles were removed i.v. THF (15 ml) and DABCO (0.351 g,
3.13 mmol) were added under vigorous stirring to the residue, and the mixture
was stirred at r.t. for 30 min. The solid was removed by filtration under N2 and
washed with THF. To the filtrate, NaN3 (0.617 g, 9.49 mmol) was added, and the
resulting mixture was stirred at r.t. for 4 d. After addition of Et2O, the resulting
suspension was filtered over a Celite pad, and the solvent was removed i.v. CC
(SiO2, AcOEt/hexane 6:4, Et3N (1%)) yielded 3a (0.542 g, 58%). Pale yellow oil.
IR (film): 3434w, 3388w, 3063w, 2976s, 2942s, 2879m, 1771vs, 1703vs, 1598m,
1581w, 1450s, 1417m, 1369s, 1345m, 1277s, 1233vs, 1174vs, 1095m, 1001w,
964s, 911w , 846w , 819w , 758m , 690s . 1H-NMR (300 MHz): 7.91–7.88,
7.65–7.59, 7.52–7.47 (3m , 5 arom. H); 5.47–5.32 (m , CH2CO); 4.50 (br. s,
CH(α )(Pro)); 3.74–3.67, 3.62–3.54 (2m , CH2(δ)(Pro)); 2.50–2.04 (m ,
CH2(β)(Pro), CH2(γ)(Pro)); 1.35, 1.31 (2s, 2 Me). 13C-NMR (75 MHz): 191.5 (s,
CO(carbonyl)); 171.7 (s, CO(ester)); 165.5 (s, C(3)); 134.1 (d, 1 arom. CH); 134.0
(s, 1 arom. C); 129.0, 127.7 (2d, 4 arom. CH); 66.4 (t, CH2CO); ca. 60.9 (br. d,
CH(α)(Pro)); ca. 46.9 (br. t, CH2(δ)(Pro)); 39.2 (s, C(2)); 30.6 (t, CH2(β)(Pro));
25.2 (q, 2 Me); 24.0 (t, CH2(γ)(Pro)). ESI-MS (MeOH): 323 (100, [M+Na]+).
Anal. calc. for C17H20N2O3  (300.35): C 67.98, H 6.71, N 9.33; found: C 67.73, H
6.53, N 9.35.
Allyl N-(2,2-Dimethyl-2H-azirin-3-yl)-L-prolinate (3b). A soln. of COCl2 in
toluene (20%, 2.6 ml, 5.02 mmol) was added to a soln. of 10b (1.008 g, 4.14
14
mmol) and 3 drops of DMF in CH2Cl2 (10 ml) at 0°, the mixture was stirred for 30
min at 0°, and the volatiles were removed i.v. The residue was dissolved in THF
(15 ml), DABCO (0.465 g, 4.15 mmol) was added, and the mixture was stirred at
r.t. for 30 min. The solid was removed by filtration under N2 and washed with
THF. To the filtrate, NaN3 (0.810 g, 12.46 mmol) was added, and the resulting
mixture was stirred at r.t. for 4 d. After addition of Et2O, the resulting suspension
was filtered over a Celite pad, and the solvent was removed i.v. CC (SiO2,
AcOEt/hexane 6:4, Et3N (1%)) yielded 3b (0.575 g, 63%). Pale yellow oil. IR
(film): 3458w, 3087w, 2976s, 2943s, 2879s, 1770vs, 1745vs, 1649w, 1454s,
1413m, 1368s, 1352m, 1272s, 1235s, 1177vs, 1093m, 1043w, 1015m, 987s, 933m.
1H-NMR (300 MHz): 5.97–5.84 (m , CH2=CH ); 5.36–5.24 (m , CH 2=CH);
4.67–4.61 (m, CH2O); 4.35–4.34 (m, CH(α)(Pro)); 3.70–3.52 (m, CH2(δ)(Pro));
2.39–1.99 (m, CH2(β)(Pro), CH2(γ)(Pro)); 1.32, 1.29 (2s, 2 Me). 13C-NMR (75
MHz): 171.6 (s, CO); 165.2 (s, C(3)); 131.4 (d, CH2=CH); 118.8 (t, CH2=CH);
65.8 (t, CH2O); ca. 60.8 (br. d, CH2(δ)(Pro)); ca. 46.9 (br. t, CH2(δ)(Pro)); 39.0 (s,
C(2)); 30.2 (t, CH2(β)(Pro)); 25.0 (q, 2 Me); 23.9 (t, CH2(γ)(Pro)). ESI-MS
(MeOH): 255 (23, [M+H+MeOH]+), 245 (100, [M+Na]+), 223 (29, [M+H]+), 196
(25). Anal. calc. for C12H18N2O2⋅0.2 H2O (225.88): C 63.81, H 8.21, N 12.40;
found: C 63.85, H 8.12, N 12.32.
3. Reactions of 2H-Azirin-3-amines 3a and 3b with PhCOSH. Phenacyl N-[2-
(Benzoylamino)-2-methyl-1-thioxopropyl]-L-prolinate (11a). A soln. of PhCOSH
(20 mg, 0.145 mmol) in CH2Cl2 (2 ml) was added to a soln. of 3a (40 mg, 0.133
mmol) in CH2Cl2 (2.5 ml) at 0°. The mixture was stirred at r.t. overnight, the
solvent was evaporated, and the crude product was purified by prep. TLC
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(CH2Cl2/MeOH 50:1, 2 × dev.; CH2Cl2/MeOH 30:1, 1 × dev.) to give 11a (54 mg,
93%). Colorless crystals. M.p. 189.1–190.2°. IR: 3361m, 3301m, 3059w, 2984m,
2932m, 2881w, 1749vs, 1702vs, 1642vs, 1598s, 1579s, 1524vs, 1486s, 1449vs,
1419vs, 1385s, 1362s, 1341m, 1301s, 1288s, 1264s, 1226vs, 1186vs, 1160vs,
1092m, 1074m, 1043s, 1028m, 1001m, 965s, 911w, 884w, 803w, 754s, 720s,
690vs. 1H-NMR (600 MHz): 8.51 (s, NH); 7.90–7.86, 7.63–7.60, 7.51–7.48,
7.45–7.43 (4m, 10 arom. H); 5.53, 5.27 (AB, J = 16.4, CH2CO); 5.38–5.36 (m,
CH(α)(Pro)); 4.12–4.08, 3.96–3.92 (2m, CH2(δ)(Pro)); 2.51–2.48, 2.39–2.31,
2.14–2.10 (3m, CH2(β)(Pro), CH2(γ)(Pro)); 1.95, 1.89 (2s, 2 Me). 13C-NMR (150
MHz): 205.9 (s, CS); 192.1 (s, CO(carbonyl)); 169.8 (s, CO(ester)); 164.9 (s,
CO(amide)); 135.0 (s, 1 arom. C); 134.0 (d, 1 arom. CH); 134.0 (s, 1 arom. C);
131.4, 128.9, 128.5, 127.7, 127.0 (5d, 9 arom. CH); 69.1 (d, CH(α)(Pro)); 66.3 (t,
CH2CO); 61.2 (s, C(α)(Aib)); 53.6 (t, CH2(δ)(Pro)); 28.0 (t, CH2(β)(Pro)); 26.0 (t,
CH2(γ)(Pro)); 25.8, 24.9 (2q, 2 Me). ESI-MS (MeOH): 461 (100, [M+Na]+). Anal.
calc. for C24H26N2O4S  (438.54): C 65.73, H 5.98, N 6.39, S 7.31; found: C 65.33,
H 5.72, N 6.24, S 7.02. Suitable crystals for the X-ray crystal-structure
determination were grown from CDCl3/Et2O.
Allyl N-[2-(Benzoylamino)-2-methyl-1-thioxopropyl]-L-prolinate (11b). A
soln. of PhCOSH (27 mg, 0.195 mmol) in CH2Cl2 (3 ml) was added to a soln. of
3b (40 mg, 0.180 mmol) in CH2Cl2 (2 ml) at 0°. The mixture was stirred at r.t.
overnight, the solvent was evaporated, and the crude product was purified by
prep. TLC (CH2Cl2/MeOH 40:1, Et3N (0.5%), 2 × dev.) to give 11b (61 mg,
94%). Colorless powder. M.p. 46.5–48.0°. IR: 3303m, 3059w, 2984m, 2925s,
2880m, 2853m, 1741vs, 1639vs, 1602m, 1578m, 1530vs, 1488s, 1461s, 1419vs,
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1385s, 1362s, 1340m, 1301s, 1292s, 1271s, 1245m, 1187vs, 1160vs, 1086w,
1075w, 1046s, 1028w, 988m, 969m, 931m, 885w, 803w, 717s, 694m. 1H-NMR
(300 MHz): 8.66 (br. s, NH); 7.89–7.85, 7.52–7.40 (2m, 5 arom. H); 5.99–5.86
(m , CH2=CH); 5.39–5.20 (m , CH2=CH, CH(α)(Pro)); 4.65–4.63 (m , CH2O);
4.08–3.91 (m , CH2(δ)(Pro)); 2.34–2.15, 2.10–2.00 (2m , CH2(β)(Pro),
CH2(γ)(Pro)); 1.95, 1.89 (2s, 2 Me). 13C-NMR (75 MHz): 205.8 (s, CS); 170.0,
164.7 (2s, 2 CO); 135.1 (s, 1 arom. C); 131.7, 131.2, 128.4, 126.9 (4d, 5 arom.
CH, CH2=CH); 118.6 (t, CH2=CH); 68.9 (d, CH(α)(Pro)); 65.8 (t, CH2O); 61.0 (s,
C(α)(Aib)); 53.4 (t, CH2(δ)(Pro)); 27.8 (t, CH2(β)(Pro)); 25.8 (t, CH2(γ)(Pro));
25.5, 24.7 (2q, 2 Me(Aib)). ESI-MS (MeOH): 383 (100, [M+Na]+), 367 (17,
[M(S→O)+Na]+). Anal. calc. for C19H24N2O3S (360.47): C 63.31, H 6.71, N 7.77,
S 8.90; found: C 63.25, H 6.45, N 7.68, S 8.67.
4. Synthesis of Model Peptides.  Phenacyl N-{2-[(2(S),3(S)-2-
{[(Benzyloxy)carbonyl]amino}-3-methyl-1-oxopentyl)amino]-2-methyl-1-
oxopropyl}-L-prolinate (12a). A soln. of 3a (65 mg, 0.216 mmol) in CH2Cl2 (2.5
ml) was added to a soln. of Z-Ile-OH (57 mg, 0.215 mmol) in CH2Cl2 (2.5 ml) at
0°. The mixture was stirred at r.t. overnight, the solvent was evaporated, and the
crude product was purified by CC (SiO2, CH2Cl2/MeOH 60:1) to give 12a (105
mg, 86%). Colorless solid. M.p. 70.1–71.5°. IR: 3318s, 3064w, 3034w, 2966s,
2936m, 2877m, 1753vs, 1702vs, 1660vs, 1633vs, 1599m, 1531vs, 1468s, 1451s,
1409vs, 1378s, 1363s, 1286s, 1230vs, 1167vs, 1096m, 1042m, 1028m, 1001w,
977m, 754s, 693s . 1H-NMR (600 MHz): 7.89–7.88, 7.62–7.59, 7.50–7.47,
7.37–7.31 (4m , 10 arom. H); 6.97 (s, NH(Aib)); 5.57, 5.21 (AB , J = 16.4,
CH2CO); 5.41 (d, J = 8.8, NH(Ile)); 5.12, 5.08 (AB, J = 12.3, CH2(carbamate));
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4.72–4.69 (m, CH(α)(Pro)); 4.00–3.97 (m, CH(α)(Ile)); 3.77–3.73, 3.57–3.54 (2m,
CH2(δ)(Pro)); 2.32–2.30 (m , 1 H of CH2(β)(Pro)); 2.19–2.10 (m , 1 H of
CH2(β)(Pro), 1 H of CH2(γ)(Pro)); 1.90–1.88 (m, 1 H of CH2(γ)(Pro)); 1.83–1.82
(m , CH(β)(Ile)); 1.65, 1.61 (2s, 2 Me(Aib)); 1.53–1.48, 1.16–1.11 (2m ,
CH2(γ)(Ile)); 0.92 (d, J = 6.8, MeCH(β)(Ile)); 0.89 (t, J = 7.4, MeCH2(γ)(Ile)). 13C-
NMR (150 MHz): 192.2 (s, CO(carbonyl)); 172.2 (s, CO(Aib)); 171.8 (s,
CO(Pro)); 169.6 (s, CO(Ile)); 156.2 (s, CO(carbamate)); 136.3, 134.1 (2s, 2 arom.
C); 134.0, 128.9, 128.5, 128.2, 128.0, 127.7 (6d, 10 arom. CH); 66.9 (t, PhCH2);
66.2 (t, CH2CO); 60.9 (d, CH(α)(Pro)); 59.7 (d, CH(α)(Ile)); 57.1 (s, C(α)(Aib));
48.2 (t, CH2(δ)(Pro)); 37.8 (d, CH(β)(Ile)); 27.9 (t, CH2(β)(Pro)); 25.8 (t,
CH2(γ)(Pro)); 24.9 (t, CH2(γ)(Ile)); 23.6, 23.2 (2q , 2 Me(Aib)); 15.4 (q ,
MeCH(β)(Ile)); 11.4 (q, MeCH2(γ)(Ile)). ESI-MS (MeOH): 588 (100, [M+Na]+).
Anal. calc. for C31H39N3O7 (565.66): C 65.82, H 6.95, N 7.43; found: C 65.53, H
7.06, N 7.27.
Allyl  N - { 2 - [ ( 2 (S),3(S)-2-{[(Benzyloxy)carbonyl]amino}-3-methyl-1-
oxopentyl)amino]-2-methyl-1-oxopropyl}-L-prolinate (12b). A soln. of 3b (60 mg,
0.270 mmol) in CH2Cl2 (3 ml) was added to a soln. of Z-Ile-OH (79 mg, 0.297
mmol) in CH2Cl2 (2 ml) at 0°. The mixture was stirred at r.t. overnight, the solvent
was evaporated, and the crude product was purified by CC (SiO2, CH2Cl2/MeOH
20:1) to give 12b (123 mg, 93%). Colorless powder. M.p. 135.0–136.1°. IR:
3287s, 3256s, 3065m, 2964s, 2937m, 2876w, 1751vs, 1715vs, 1666vs, 1619vs,
1547vs, 1497m, 1453s, 1419s, 1383s, 1366m, 1355m, 1285s, 1272s, 1243vs,
1208m, 1174vs, 1162vs, 1126m, 1095w, 1047m, 1028m, 987m, 949w, 923w,
877w, 853w, 778w, 751w, 738m, 700m. 1H-NMR (600 MHz): 7.37–7.29 (m, 5
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arom. H); 6.97 (br. s, NH(Aib)); 5.94–5.87 (m, CH2=CH); 5.40 (d , J = 8.5,
NH(Ile)); 5.35–5.31, 5.25–5.23 (2m, CH2=CH); 5.11, 5.08 (A B , J  = 12.3,
CH2(carbamate)); 4.66–4.58 (m, CH2O); 4.58–4.55 (m, CH(α)(Pro)); 4.00–3.97
(m, CH(α)(Ile)); 3.72–3.69, 3.58–3.55 (2m, CH2(δ)(Pro)); 2.11–2.07 (m, 1 H of
CH2(β)(Pro)); 2.04–1.97 (m , 1 H of CH2(γ)(Pro)); 1.91–1.82 (m , 1 H of
CH2(β)(Pro), 1 H of CH2(γ)(Pro), CH(β)(Ile)); 1.65, 1.62 (2s, 2 Me(Aib));
1.53–1.49, 1.16–1.10 (2m, CH2(γ)(Ile)); 0.92 (d, J = 7.0, MeCH(β)(Ile)); 0.90 (t, J
= 7.4, MeC H2(γ)(Ile)). 13C-NMR (150 MHz): 172.0 (s, CO(Aib)); 172.0 (s,
CO(Pro)); 169.6 (s, CO(Ile)); 156.2 (s, CO(carbamate)); 136.4 (s, 1 arom. C);
131.9 (d, CH2=CH); 128.5, 128.2, 128.0 (3d, 5 arom. CH); 118.5 (t, CH2=CH);
66.9 (t, CH2(carbamate)); 65.7 (t, CH2O); 61.0 (d , CH(α )(Pro)); 59.7 (d,
CH(α)(Ile)); 57.1 (s, C(α)(Aib)); 48.1 (t, CH2(δ)(Pro)); 37.8 (d, CH(β)(Ile)); 27.8
(t, CH2(β)(Pro)); 25.8 (t, CH2(γ)(Pro)); 24.9 (t, CH2(γ)(Ile)); 23.5, 23.1 (2q, 2
Me(Aib)); 15.4 (q, MeCH(β)(Ile)); 11.4 (q, MeCH2(γ)(Ile)). ESI-MS (MeOH):
510 (100, [M+Na]+). Anal. calc. for C26H37N3O6 (487.59): C 64.05, H 7.65, N
8.62; found: C 63.89, H 7.40, N 8.58.
Phenacyl N -{2-[((S )-2-{[(Benzyloxy)carbonyl]amino}-3-phenyl-1-
oxopropyl)amino]-2-methyl-1-oxopropyl}-L-prolinate (13). A soln. of 3a (120
mg, 0.380 mmol) in CH2Cl2 (3 ml) was added to a soln. of Z-Phe-OH (120 mg,
0.401 mmol) in CH2Cl2 (3 ml) at 0°. The mixture was stirred at r.t. overnight, the
solvent was evaporated, and the crude product was purified by CC (SiO2,
CH2Cl2/MeOH 80:1 → 60:1) to give 13 (213 mg, 94%). Colorless powder. M.p.
76.7–78.4°. IR: 3311s, 3062m, 3031w, 2983m, 2940m, 2880w, 1752vs, 1703vs,
1670vs, 1625vs, 1532vs, 1498s, 1469s, 1451s, 1412vs, 1377s, 1364s, 1341m,
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1286s, 1232vs, 1166vs, 1097w, 1084w, 1052m, 1028m, 1001w, 977m, 913w,
848w, 752s, 698s . 1H-NMR (600 MHz): 7.88–7.87, 7.61–7.59, 7.49–7.46,
7.37–7.20 (4m , 15 arom. H); 6.57 (s, NH(Aib)); 5.55, 5.18 (AB , J = 16.5,
CH2CO); 5.39 (d, J = 7.2, NH(Phe)); 5.10, 5.08 (AB, J = 12.0, CH2(carbamate));
4.68–4.66 (m, CH(α)(Pro)); 4.38–4.37 (m, CH(α)(Phe)); 3.66–3.59, 3.46–3.42
(2m, CH2(δ)(Pro)); 3.11–3.08, 3.03–3.00 (2m, CH2(Phe)); 2.32–2.26, 2.19–2.13
(2m, CH2(β)(Pro)); 2.10–2.06, 1.92–1.84 (2m, CH2(γ)(Pro)); 1.50, 1.42 (2s, 2
Me(Aib)). 13C-NMR (150 MHz): 192.2 (s, CO(carbonyl)); 171.8 (s, CO(Aib),
CO(Pro)); 169.1 (s, CO(Phe)); 155.9 (s, CO(carbamate)); 136.3, 136.2, 134.1 (3s,
3 arom. C); 134.0, 129.5, 128.9, 128.7, 128.6, 128.2, 128.0, 127.7, 127.1 (9d, 15
arom. CH); 67.0 (t, CH2(carbamate)); 66.1 (t, CH2CO); 60.8 (d, CH(α)(Pro)); 56.9
(s, C(α)(Aib)); 56.4 (d, CH(α)(Phe)); 48.1 (t, CH2(δ)(Pro)); 38.7 (t, CH2(Phe));
27.8 (t, CH2(β)(Pro)); 25.8 (t, CH2(γ)(Pro)); 23.7, 23.4 (2q, 2 Me(Aib)). ESI-MS
(MeOH): 622 (100, [M+Na]+). Anal. calc. for C34H37N3O7 (599.67): C 68.10, H
6.22, N 7.01; found: C 68.13, H 6.27, N 6.90.
N-{2-[((S)-2-{[(Benzyloxy)carbonyl]amino}-3-phenyl-1-oxopropyl)amino]-2-
methyl-1-oxopropyl}-L-proline (14). Zn-powder (274 mg, 4.190 mmol) was added
to a soln. of 13 (50 mg, 0.083 mmol) in AcOH (100%, 2 ml) and the mixture was
stirred at r.t. for 45 min. Additional Zn-powder (136 mg, 2.080 mmol) and AcOH
(100%, 0.5 ml) were added and the mixture was stirred for further 45 min. The
mixture was filtered, the residue washed with AcOH, and the filtrate was
concentrated under reduced pressure. Prep. TLC (CH2Cl2/MeOH 10:1, 2 × dev.)
yielded 14 (30 mg, 75%). Colorless powder. M.p. 94.4–96.3°. IR: 3305vs, 3063s,
3032s, 2984s, 2945s, 2879m, 1720vs, 1666vs, 1620vs, 1537vs, 1498vs, 1469s,
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1454vs, 1419vs, 1383s, 1366s, 1341s, 1294sh, 1245vs, 1217s, 1178s, 1152s,
1084w, 1053s, 1028m, 912w, 744s, 699vs. 1H-NMR (600 MHz): 7.37–7.21 (m, 10
arom. H); 6.58 (br. s, NH(Aib)); 5.43 (br. s, NH(Phe)); 5.12, 5.07 (AB, J = 12.1,
CH2(carbamate)); 4.57–4.54 (m, CH(α)(Pro)); 4.41 (q-like, J ≈ 7.4, CH(α)(Phe));
3.39–3.35 (m, 1 H of CH2(δ)(Pro)); 3.07–3.05 (m, CH2(Phe)); 2.96–2.94 (m, 1 H
of CH2(δ)(Pro)); 2.09–1.95 (m, CH2(β)(Pro)); 1.78–1.68 (m, CH2(γ)(Pro)); 1.37 (s,
2 Me(Aib)); COOH could not be detected. 13C-NMR (150 MHz): 173.0 (s,
CO(Pro)); 172.7 (s, CO(Aib)); 170.4 (s, CO(Phe)); 156.3 (s, CO(carbamate));
136.0, 135.9 (2s, 2 arom. C); 129.5, 128.8, 128.6, 128.4, 128.1, 127.2 (6d, 10
arom. CH); 67.4 (t, CH2(carbamate)); 61.6 (d, CH(α)(Pro)); 56.9 (s, C(α)(Aib));
56.1 (d , CH(α )(Phe)); 48.2 (t, CH2(δ)(Pro)); 37.4 (t, CH2(Phe)); 27.3 (t,
CH2(β)(Pro)); 25.9 (t, CH2(γ)(Pro)); 24.8, 24.3 (2q, 2 Me(Aib)). ESI-MS (MeOH):
504 (100, [M+Na]+). Anal. calc. for C26H31N3O6⋅H2O (499.56): C 62.51, H 6.66, N
8.41; found: C 62.80, H 6.47, N 8.27.
N-{2-[(2(S),3(S)-2-{[(Benzyloxy)carbonyl]amino}-3-methyl-1-
oxopentyl)amino]-2-methyl-1-oxopropyl}-L-proline (15). A soln. of Pd(Ph3P)4 (ca.
4 mg, ca. 0.004 mmol) and PhSiH3 (70 µl, 0.567 mmol) in CH2Cl2 (1 ml) was
added to a soln. of 12b (70 mg, 0.144 mmol) in CH2Cl2 (1 ml) and the mixture
was stirred at r.t. under Ar and exclusion of light for 50 min. The mixture was
concentrated i.v. and purified by prep. TLC (CH2Cl2/MeOH 10:1, 3 × dev.) to give
15 (54 mg, 84%). Colorless powder. M.p. 101.5–103.2°. IR: 3426s, 3306vs,
3063s, 3035s, 2966vs, 2936s, 2878s, 1705vs, 1659vs, 1622vs, 1535vs, 1469s,
1454vs, 1416vs, 1384s, 1365s, 1342s, 1309s, 1288s, 1245vs, 1178s, 1128m,
1094m, 1042s, 1028m, 983w, 914w, 882w, 778w, 739m, 698s. 1H-NMR (600
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MHz): 7.34–7.31 (m, 5 arom. H); 7.10 (br. s, NH(Aib)); 5.69 (br. s, NH(Ile));
5.11, 5.07 (AB, J = 11.8, CH2(carbamate)); 4.55 (br. s, CH(α)(Pro)); 3.97 (br. s,
CH(α)(Ile)); 3.49 (br. s, CH2(δ)(Pro)); 2.08–1.83 (m , CH2(β)(Pro), 1 H of
CH2(γ)(Pro), CH(β)(Ile)); 1.75–1.67 (m, 1 H of CH2(γ)(Pro)); 1.53, 1.51 (2s, 2
Me(Aib)); ca. 1.50, 1.67–1.09 (2m, CH2(γ)(Ile)); 0.92 (d, J = 7.1, MeCH(β)(Ile));
0.88 (t, J = 7.1, M eCH2(γ)(Ile)); COOH could not be detected. 13C-NMR (150
MHz): 173.9, 173.0, 171.1 (3s, 3 CO); 156.6 (s, CO(carbamate)); 136.2 (s, 1
arom. C); 128.6, 128.3, 128.0 (3d, 5 arom. CH); 67.1 (t, CH2(carbamate)); 61.7 (d,
CH(α)(Pro)); 59.8 (d, CH(α)(Ile)); 57.0 (s, C(α)(Aib)); 48.2 (t, CH2(δ)(Pro)); 36.8
(d, CH(β)(Ile)); 27.4 (t, CH2(β)(Pro)); 25.9 (t, CH2(γ)(Pro)); 24.8 (t, CH2(γ)(Ile));
24.5, 24.4 (2q, 2 Me(Aib)); 15.5 (q, MeCH(β)(Ile)); 11.2 (q, MeCH2(γ)(Ile)). ESI-
MS (MeOH): 486 (19, [M+K]+), 470 (100, [M+Na]+), 305 (57, [M–Pro–CO]+).
Anal. calc. for C23H33N3O6⋅H2O (465.54): C 59.34, H 7.58, N 9.03; found: C
59.46, H 7.41, N 8.69.
5. Synthesis of Thioamides  8a–c. (9H-Fluoren-9-yl)methyl N-(2-
Methylpropanoyl)-L-prolinate (7a). At 0°, DCC (1.227 g, 5.95 mmol) was added
to a soln. of 6 (1.000 g, 5.40 mmol), 9H-fluoren-9-ylmethanol (1.166 g, 5.94
mmol) and PPY (42 mg, 0.283 mmol) in CH2Cl2 (50 ml). After stirring at r.t. for 4
h, the mixture was filtered, and the solvent was evaporated. CC (SiO2,
AcOEt/hexane: 4:6 → 6:4) yielded 7a (1.786 g, 91%). Colorless powder. M.p.
104.4–107.3°. IR: 2971m, 2951m , 2932m , 2892w, 2873m , 1750vs, 1707w ,
1629vs, 1536w, 1471s, 1446s, 1432vs, 1381m, 1329s, 1320m, 1270m, 1196s,
1167vs, 1088m, 1035m, 1024w, 1003w, 955w, 945w, 903w, 752s, 741s. 1H-NMR
(300 MHz, conformers (86:14)): 7.78–7.73, 7.64–7.54, 7.42–7.27 (3m, 8 arom.
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H); 4.64–4.59 (m, CH(α)(Pro)); 4.53–4.43 (m , CH2(Fm)); 4.21 (t, J  = 6.3,
CH(Fm)); 3.52–3.46 (m, CH2(δ)(Pro)); 2.60 (sept., J = 6.8, Me2CH); 2.11–2.01,
1.91–1.65 (2m, CH2(β)(Pro), CH2(γ)(Pro)); 1.10, 1.06 (2d, J = 6.8, 2 Me). 13C-
NMR (75 MHz): 175.9, 172.4 (2s, 2 CO); 144.1, 143.7, 141.4, 141.4 (4s, 4 arom.
C); 127.8, 127.2, 125.1, 125.0, 119.9 (5d, 8 arom. CH); 66.2 (t, CH2(Fm)); 58.8
(d, CH(α)(Pro)); 47.1 (d, CH(Fm)); 46.7 (t, CH2(δ)(Pro)); 32.3 (d, Me2CH); 29.0,
24.7 (2t, CH2(β)(Pro), CH2(γ)(Pro)); 18.8, 18.7 (2q, 2 Me). ESI-MS (MeOH): 414
(19, [M+H+H2O+MeOH]+), 386 (100, [M+Na]+).
2-[(4-Nitrophenyl)sulfonyl]ethyl N-(2-Methylpropanoyl)-L-prolinate (7b). A
soln. of 2-(4-nitrophenylsulfonyl)ethanol (433 mg, 1.873 mmol), EDCI (474 mg,
2.473 mmol), DMAP (24 mg, 0.196 mmol) and 6 (381 mg, 2.057 mmol) in
CH2Cl2 (30 ml) was stirred under N2 at r.t. for 1 d. Aq. AcOH (5%, ca. 40 ml) was
added, and the mixture was extracted with CH2Cl2. The combined org. layers were
dried (Na2SO4) and concentrated i.v. CC (SiO2, CH2Cl2/MeOH 50:1) yielded 7b
(683 mg, 92%). Colorless powder. M.p. 89.8–91.9°. IR: 3463w, 3119w, 2975s,
2931m, 2879w, 1740vs, 1642vs, 1608m, 1530vs, 1467m, 1428vs, 1391m, 1351vs,
1330vs, 1312vs, 1302vs, 1270w, 1248m, 1210m, 1179vs, 1146vs, 1104m, 1089s,
1046w, 1010m, 994w, 919w, 857m, 840w, 805w, 757s, 739s, 703s. 1H-NMR (300
MHz, conformers (96:4)): 8.44–8.40, 8.20–8.15 (2m, 4 arom. H); 4.51–4.46 (m,
CH2CH2O); 4.16–4.12 (m, CH(α)(Pro)); 3.67–3.49 (m, CH2CH2O, CH2(δ)(Pro));
2.64 (sept., J = 6.8, Me2CH); 2.11–1.86 (m, CH2(β)(Pro), CH2(γ)(Pro)); 1.12, 1.10
(2d , J  = 6.8, 2 Me). 13C-NMR (75 MHz): 176.0 (s, CO(amide)); 171.8 (s,
CO(ester)); 151.0, 144.8 (2s, 2 arom. C); 129.9, 124.6 (2d, 4 arom. CH); 58.5 (d,
CH(α)(Pro)); 57.5 (t, CH2CH2O); 55.1 (t, CH2CH2O); 46.8 (t, CH(δ)(Pro)); 32.2
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(d, Me2CH); 28.8, 25.0 (2t, CH2(β)(Pro), CH2(γ)(Pro)); 18.8, 18.7 (2q, 2 Me). ESI-
MS (MeOH, NaI): 421 (100, [M+Na]+).
2-[(4-Nitrophenyl)sulfanyl]ethyl N-(2-Methylpropanoyl)-L-prolinate (7c). At
0°, DCC (513 mg, 2.486 mmol) was added to a soln. of 6 (420 mg, 2.268 mmol),
2-(4-nitrophenylsulfanyl)ethanol (470 mg, 2.359 mmol) and PPY (38 mg, 0.256
mmol) in CH2Cl2 (20 ml). After stirring at r.t. for 5.5 h, the mixture was filtered,
and the solvent was evaporated. CC (SiO2, AcOEt/hexane: 6:4) yielded 7c (807
mg, 97%). Yellow oil. IR (film): 3469w, 3327w, 3100m, 3069w, 2972vs, 2933vs,
2876s, 1745vs, 1643vs, 1594vs, 1578vs, 1512vs, 1471vs, 1427vs, 1381vs,
1338vs, 1322sh, 1274vs, 1243s, 1171vs, 1090vs, 1046s, 1009s, 966m, 953m,
916w, 886w, 853vs, 742vs. 1H-NMR (600 MHz, conformers (92:8)): 8.18–8.13,
7.44–7.40 (2m , 4 arom. H); 4.45–4.43 (m , CH(α )(Pro)); 4.39–4.30 (m,
CH2CH2O); 3.71–3.67, 3.60–3.56 (2m, CH2(δ)(Pro)); 3.31–3.27 (m, CH2CH2O);
2.69 (sept., J = 6.8, Me2CH); 2.21–2.16, 2.11–2.07, 2.02–1.93 (3m, CH2(β)(Pro),
CH2(γ)(Pro)); 1.16, 1.13 (2d, J = 6.8, 2 Me). 13C-NMR (150 MHz): 176.0 (s,
CO(amide)); 172.3 (s, CO(ester)); 146.0, 145.4 (2s, 2 arom. C); 126.7, 124.1 (2d,
4 arom. CH); 62.5 (t, CH2CH2O); 58.8 (d, CH(α)(Pro)); 46.8 (t, CH2(δ)(Pro));
32.3 (d, Me2CH); 30.3 (t, CH2CH2O); 29.1 (t, CH2(β)(Pro)); 25.0 (t, CH2(γ)(Pro));
18.9, 18.7 (2q, 2 Me). ESI-MS (CH2Cl2,MeOH, NaI): 389 (100, [M+Na]+).
(9H-Fluoren-9-yl)methyl N-(2-Methylpropanthioyl)-L-prolinate (8a). A
suspension of Lawesson reagent (dried i.v., 307 mg, 0.759 mmol) and 7a (499 mg,
1.373 mmol) in toluene (15 ml) was heated at 95° (oilbath) for 1 h. After cooling
to r.t., the mixture was filtered, and the solvent was evaporated. CC (SiO2,
AcOEt/hexane 2:8) yielded 8a  (369 mg, 71%). Colorless powder. M.p.
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174.1–176.3°. IR: 2974m, 2964m, 2927m, 2873w, 1743vs, 1595w, 1554w, 1503w,
1461s, 1440vs, 1383s, 1359m, 1345s, 1336s, 1300w, 1270s, 1255m, 1229m,
1194vs, 1171vs, 1156vs, 1123s, 1020m, 1006s, 975m, 939m, 761s, 742vs, 716w.
1H-NMR (300 MHz, conformers (88:12)): 7.78–7.58, 7.42–7.27 (2m, 8 arom. H);
5.10–5.06 (m, CH(α)(Pro)); 4.73 (dd, J = 10.8, 5.6, 1 H of CH2(Fm)); 4.42 (dd, J
= 10.8, 6.4, 1 H of CH2(Fm)); 4.24 (t-like, J ≈ 6.0, CH(Fm)); 3.68–3.63 (m,
CH2(δ)(Pro)); 2.94 (sept ., J  = 6.6, Me2CH); 2.17–2.07, 1.96–1.73 (2m,
CH2(β)(Pro), CH2(γ)(Pro)); 1.21, 1.11 (2d, J = 6.5, 2 Me)). 13C-NMR (CDCl3, 75
MHz): 209.7 (s, CS); 170.5 (s, CO); 144.0, 143.6, 141.4, 141.4 (4s, 4 arom. C);
127.8, 127.2, 125.2, 125.0, 119.9 (5d, 8 arom. H); 66.2 (t, CH2(Fm)); 65.3 (d,
CH(α)(Pro)); 50.1 (t, CH2(δ)(Pro)); 47.1 (d, CH(Fm)); 38.7 (d, Me2CH); 28.7,
24.5 (2t, CH2(β)(Pro), CH2(γ)(Pro)); 22.6, 22.4 (2q, 2 Me). ESI-MS (MeOH): 402
(100, [M+Na]+).
2-[(4-Nitrophenyl)sulfonyl]ethyl N-(2-Methylpropanthioyl)-L-prolinate (8b). A
suspension of Lawesson reagent (dried i.v., 374 mg, 0.925 mmol) and 7b (662 mg,
1.662 mmol) in toluene (20 ml) was heated at 90° (oilbath) for 1 h. After cooling
to r.t., the mixture was filtered, and the solvent was evaporated. CC (SiO2,
CH2Cl2/MeOH 70:1) yielded 8b  (509 mg, 74%). Yellow powder. M.p.
174.1–176.3°. IR: 3470w, 3109w, 3062w, 3033w, 2966s, 2924s, 2887m, 2864w,
1742vs, 1606m, 1524vs, 1475vs, 1458vs, 1402m, 1377s, 1350vs, 1327vs, 1303vs,
1264s, 1253s, 1226s, 1196vs, 1174vs, 1152vs, 1124s, 1106m, 1086s, 1070s,
1013s, 999m, 977m, 921w, 881w, 851s, 828w, 789w, 756vs, 738vs, 702vs. 1H-
NMR (300 MHz, conformers (95:5)): 8.47–8.41, 8.20–8.14 (2m, 4 arom. H);
4.77–4.73 (m, CH(α)(Pro)); 4.61–4.44 (m, CH2CH2O); 4.13–3.85, 3.78–3.69 (2m,
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CH2(δ)(Pro)); 3.63–3.46 (m, CH2CH2O); 3.02 (sept., J = 6.6, Me2CH); 2.24–1.98
(m, CH2(β)(Pro), CH2(γ)(Pro)); 1.21, 1.21 (2d , J  = 6.5, 2 Me). 13C-NMR (75
MHz): 209.9 (s, CS); 169.8 (s, CO); 151.0, 144.8 (2s, 2 arom. C); 129.9, 124.6
(2d, 4 arom. CH); 65.0 (d, CH(α)(Pro)); 57.6 (t, CH2CH2O); 55.1 (t, CH2CH2O);
50.3 (t, CH2(δ)(Pro)); 38.7 (d, Me2CH); 28.5, 24.8 (2t, CH2(β)(Pro), CH2(γ)(Pro));
22.7, 22.4 (2q, 2 Me). ESI-MS (MeOH, NaI): 437 (100, [M+Na]+), 206 (25).
2-[(4-Nitrophenyl)sulfanyl]ethyl N-(2-Methylpropanthioyl)-L-prolinate (8c). A
suspension of Lawesson reagent (dried i.v., 473 mg, 1.170 mmol) and 7c (773 mg,
2.110 mmol) in toluene (20 ml) was heated at 90° (oilbath) for 1 h. After cooling
to r.t., the mixture was filtered, and the solvent was evaporated. CC (SiO2,
CH2Cl2/MeOH 300:1 → 100:1) yielded 8c (599 mg, 74%). Yellow oil. IR (film):
3098w, 3067w, 2971vs, 2929s, 2878s, 1743vs, 1594vs, 1578vs, 1513vs, 1479vs,
1462vs, 1441vs, 1381vs, 1338vs, 1300s, 1268vs, 1257vs, 1227vs, 1188vs,
1166vs, 1125s, 1090vs, 1049m, 1016vs, 970s, 922w, 912w, 877w, 853vs, 841s,
779w, 742vs. 1H-NMR (300 MHz, conformers (93:7)): 8.16–8.13, 7.45–7.41 (2m,
4 arom. H); 5.05–5.01 (m, CH(α)(Pro)); 4.41–4.30 (m, CH2CH2O); 3.91–3.89,
3.82–3.76 (2m, CH2(δ)(Pro)); 3.31 (t, J = 7.1, CH2CH2O); 3.06 (sept., J = 6.6,
Me2CH); 2.29–2.07 (m, CH2(β)(Pro), CH2(γ)(Pro)); 1.25, 1.25 (2d, J = 6.6, 2 Me).
13C-NMR (75 MHz): 210.1 (s, CS); 170.5 (s, CO); 146.1, 145.6 (2s, 2 arom. C);
126.8, 124.3 (2d, 4 arom. CH); 65.4 (d, CH(α)(Pro)); 62.8 (t, CH2CH2O); 50.5 (t,
CH2(δ)(Pro)); 38.9 (d, Me2CH); 30.3 (t, CH2CH2O); 29.0, 25.0 (2t, CH2(β)(Pro),
CH2(γ)(Pro)); 22.9, 22.5 (2q, 2 Me). ESI-MS (MeOH, NaI): 405 (100, [M+Na]+).
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6. X-Ray Crystal-Structure Determination of 11a (Table and Fig.)4). A crystal
of C24H26N2O4S, obtained from CDCl3/Et2O, was used for a low-temp. X-ray
crystal-structure determination. All measurements were made on a Nonius
KappaCCD area-detector diffractometer [33] using graphite-monochromated
MoKα radiation (λ 0.71073 Å) and an Oxford Cryosystems Cryostream 700
cooler. The data collection and refinement parameters are given in the Table, and
a view of the molecule is shown in the Figure. Data reduction was performed with
HKL Denzo and Scalepack [34]. The intensities were corrected for Lorentz and
polarization effects, and an absorption correction based on the multi-scan method
[35] was applied. Equivalent reflections, other than Friedel pairs, were merged.
The structure was solved by direct methods using SIR92 [36], which revealed the
positions of all non-H-atoms. The non-H-atoms were refined anisotropically. The
amide H-atom was placed in the position indicated by a difference electron
density map and its position was allowed to refine together with an isotropic
displacement parameter. All remaining H-atoms were placed in geometrically
calculated positions and refined using a riding model where each H-atom was
assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of
its parent C-atom (1.5Ueq for the Me groups). Refinement of the structure was
carried out on F2 using full-matrix least-squares procedures, which minimised the
function Σw(Fo2 – Fc2)2. A correction for secondary extinction was applied.
                                                 
4 ) CCDC 602724 contains the supplementary crystallographic data for this paper.
These data can be obtained free of charge from the Cambridge Crystallographic
Data Center via http://www.ccdc.cam.ac.uk/data_request/cif.
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Refinement of the absolute structure parameter [37] yielded a value of -0.08(6),
which confidently confirms that the refined coordinates, represent the true
enantiomorph. Neutral atom scattering factors for non-H atoms were taken from
[38a], and the scattering factors for H-atoms were taken from [39]. Anomalous
dispersion effects were included in Fc [40]; the values for f ' and f " were those of
[38b]. The values of the mass attenuation coefficients are those of [38c]. All
calculations were performed using the SHELXL97 [41] program.
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Captions
Scheme 1. a) LiOH · H2O, THF, MeOH, H2O, r.t.; b) for 7a: 9H-fluoren-9-
ylmethanol, DCC, PPY, CH2Cl2, r.t.; for 7b: 2-(4-nitrophenylsulfonyl)ethanol,
EDCI, DMAP, CH2Cl2, r.t.; for 7c: 2-(4-nitrophenylsulfanyl)ethanol, DCC, PPY,
CH2Cl2, r.t.; c) Lawesson reagent, MePh, ca. 90°; d) 1. COCl2, MePh, CH2Cl2,
DMF (cat.), 0°; 2. for 4a and 4b: EtN(iPr)2, THF, r.t.; for 4c: DABCO, THF, r.t.;
3. NaN3, THF, (DMF), r.t. For abbreviations see Experimental Part, General.
Scheme 2. a) for 9a: phenacyl bromide, Et3N, AcOEt, r.t.; for 9b: allyl bromide,
aliquat 336, CH2Cl2, NaHCO3, H2O, 0°→ r.t.; b) 1. SOCl2, allyl alcohol,
–20°→65°; 2. isobutyryl chloride, Et3N, AcOEt, 0°→r.t.; c) Lawesson reagent,
MePh, ca. 90°; d) 1. COCl2, MePh, CH2Cl2, DMF (cat.), 0°; 2. DABCO, THF, r.t.;
3. NaN3, THF, r.t. For abbreviations see Experimental Part, General.
Scheme 3.
Scheme 4.
Fig. ORTEP Plot [31] of the molecular structure of 11a (50% probability
ellipsoids; arbitrary numbering of atoms).
Table. Crystallographic Data for Compound 11a
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Table
Table. Crystallographic Data for Compound 11a
Crystallised from CDCl3/Et2O
Empirical formula C24H26N2O4S
Formula weight [g mol–1] 438.54
Crystal color, habit colorless, needle
Crystal dimensions [mm] 0.08 × 0.10 × 0.30
Temp. [K] 160(1)
Crystal system monoclinic
Space group P21
Z 2
Reflections for cell determination 30655
2θ range for cell determination [°] 4 – 55
Unit cell parameters a [Å] 9.2417(3)
b [Å] 11.1230(4)
c [Å] 11.4726(4)
β [°] 110.418(2)
V [Å3] 1105.24(7)
Dx [g cm–3] 1.318
µ(MoKα) [mm–1] 0.180
Scan type φ and ω
2θ (max) [°] 55
Transmission factors (min; max) 0.799; 0.994
Total reflections measured 24199
Symmetry independent reflections 5044
Reflections with I > 2σ (I) 4212
Reflections used in refinement 5044
Parameters refined; restraints 287; 1
Final R(F)  [I > 2σ (I) reflections] 0.0391
wR(F2)  (all data) 0.0862
Weights: w = [σ 2(Fo2) + (0.0369P)2 + 0.2109P]–1 where P = (Fo2 + 2Fc2) / 3
Goodness of fit 1.030
Final Δ max /σ 0.001
Δρ (max; min) [e Å–3] 0.19; -0.22
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